Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Prophylactic Tumor Treating Fields in Management of Patients With Small Cell Lung Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03995667
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:39:30.102526+00:00
Published At
2023-10-30T00:00:00+00:00
Record Updated At
2023-10-30
Results Posted At
2023-10-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Extensive Stage Lung Small Cell Carcinoma", "Limited Stage Lung Small Cell Carcinoma", "Stage I Lung Cancer AJCC v8", "Stage IA1 Lung Cancer AJCC v8", "Stage IA2 Lung Cancer AJCC v8", "Stage IA3 Lung Cancer AJCC v8", "Stage IB Lung Cancer AJCC v8", "Stage II Lung Cancer AJCC v8", "Stage IIA Lung Cancer AJCC v8", "Stage IIB Lung Cancer AJCC v8", "Stage III Lung Cancer AJCC v8", "Stage IIIA Lung Cancer AJCC v8", "Stage IIIB Lung Cancer AJCC v8", "Stage IIIC Lung Cancer AJCC v8", "Stage IV Lung Cancer AJCC v8", "Stage IVA Lung Cancer AJCC v8", "Stage IVB Lung Cancer AJCC v8"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2023-10-30"
protocolSection.identificationModule.nctId
"NCT03995667"
protocolSection.identificationModule.officialTitle
"Prophylactic Tumor Treating Fields in Management of Patients With Small Cell Lung Cancer"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2023-10-30"

Study condition terms

  • Extensive Stage Lung Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Limited Stage Lung Small Cell Carcinoma (protocolSection.conditionsModule.conditions)
  • Stage I Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IA1 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IA2 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IA3 Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage II Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage III Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IIIC Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IV Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVA Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)
  • Stage IVB Lung Cancer AJCC v8 (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.